Announcement on the repurchase ratio of the company's shares through centralized bidding transactions reaching 1% of the total share capital and the progress of the repurchase
Notice on changing the signed certified public accountant and project quality control reviewer
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Zhong Lun: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders of Meiland
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Nanjing Mailander Medical Technology Co., Ltd. 2024 Second Extraordinary General Meeting of Shareholders Meeting Data
Corrective notice to the announcement of the resolution of the fourth meeting of the second board of directors
Announcement of Resolutions of the Fourth Meeting of the Second Board of Directors
Announcement of Resolutions of the Third Meeting of the Second Board of Supervisors
Zhong Lun: Legal Opinions on Termination of Implementation of the 2023 Restricted Stock Incentive Plan and Repurchase and Cancellation of Class I Restricted Stocks and Cancellation of Class II Restricted Shares
Announcement on the termination of implementation of the 2023 Restricted Stock Incentive Plan and the repurchase and cancellation of Class I restricted stocks and the abolition of Class II restricted stocks
Announcement on Repurchase and Cancellation of the 2023 Restricted Stock Incentive Plan Class I Restricted Stock Capital Reduction and Notice to Creditors
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
MacLander: Investor Relations Activity Record Sheet (March 7, 2024)
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Nanjing Maillander Medical Technology Co., Ltd. 2023 Annual Results Express Announcement
Announcement on the listing and circulation of part of the initial public offering of restricted shares
Nanjing Securities Co., Ltd.\'s inspection opinion on the initial public offering of some restricted shares in Nanjing Maillander Medical Technology Co., Ltd.
Announcement on the progress of repurchasing the company\'s shares through centralized bidding transactions and the company\'s action plan to “improve quality, increase efficiency and focus on return”
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
No Data